Cargando…
Delirium in critical illness: clinical manifestations, outcomes, and management
Delirium is the most common manifestation of brain dysfunction in critically ill patients. In the intensive care unit (ICU), duration of delirium is independently predictive of excess death, length of stay, cost of care, and acquired dementia. There are numerous neurotransmitter/functional and/or in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366492/ https://www.ncbi.nlm.nih.gov/pubmed/34401939 http://dx.doi.org/10.1007/s00134-021-06503-1 |
_version_ | 1783738896828334080 |
---|---|
author | Stollings, Joanna L. Kotfis, Katarzyna Chanques, Gerald Pun, Brenda T. Pandharipande, Pratik P. Ely, E. Wesley |
author_facet | Stollings, Joanna L. Kotfis, Katarzyna Chanques, Gerald Pun, Brenda T. Pandharipande, Pratik P. Ely, E. Wesley |
author_sort | Stollings, Joanna L. |
collection | PubMed |
description | Delirium is the most common manifestation of brain dysfunction in critically ill patients. In the intensive care unit (ICU), duration of delirium is independently predictive of excess death, length of stay, cost of care, and acquired dementia. There are numerous neurotransmitter/functional and/or injury-causing hypotheses rather than a unifying mechanism for delirium. Without using a validated delirium instrument, delirium can be misdiagnosed (under, but also overdiagnosed and trivialized), supporting the recommendation to use a monitoring instrument routinely. The best-validated ICU bedside instruments are CAM-ICU and ICDSC, both of which also detect subsyndromal delirium. Both tools have some inherent limitations in the neurologically injured patients, yet still provide valuable information about delirium once the sequelae of the primary injury settle into a new post-injury baseline. Now it is known that antipsychotics and other psychoactive medications do not reliably improve brain function in critically ill delirious patients. ICU teams should systematically screen for predisposing and precipitating factors. These include exacerbations of cardiac/respiratory failure or sepsis, metabolic disturbances (hypoglycemia, dysnatremia, uremia and ammonemia) receipt of psychoactive medications, and sensory deprivation through prolonged immobilization, uncorrected vision and hearing deficits, poor sleep hygiene, and isolation from loved ones so common during COVID-19 pandemic. The ABCDEF (A2F) bundle is a means to facilitate implementation of the 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS) Guidelines. In over 25,000 patients across nearly 100 institutions, the A2F bundle has been shown in a dose–response fashion (i.e., greater bundle compliance) to yield improved survival, length of stay, coma and delirium duration, cost, and less ICU bounce-backs and discharge to nursing homes. |
format | Online Article Text |
id | pubmed-8366492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-83664922021-08-17 Delirium in critical illness: clinical manifestations, outcomes, and management Stollings, Joanna L. Kotfis, Katarzyna Chanques, Gerald Pun, Brenda T. Pandharipande, Pratik P. Ely, E. Wesley Intensive Care Med Narrative Review Delirium is the most common manifestation of brain dysfunction in critically ill patients. In the intensive care unit (ICU), duration of delirium is independently predictive of excess death, length of stay, cost of care, and acquired dementia. There are numerous neurotransmitter/functional and/or injury-causing hypotheses rather than a unifying mechanism for delirium. Without using a validated delirium instrument, delirium can be misdiagnosed (under, but also overdiagnosed and trivialized), supporting the recommendation to use a monitoring instrument routinely. The best-validated ICU bedside instruments are CAM-ICU and ICDSC, both of which also detect subsyndromal delirium. Both tools have some inherent limitations in the neurologically injured patients, yet still provide valuable information about delirium once the sequelae of the primary injury settle into a new post-injury baseline. Now it is known that antipsychotics and other psychoactive medications do not reliably improve brain function in critically ill delirious patients. ICU teams should systematically screen for predisposing and precipitating factors. These include exacerbations of cardiac/respiratory failure or sepsis, metabolic disturbances (hypoglycemia, dysnatremia, uremia and ammonemia) receipt of psychoactive medications, and sensory deprivation through prolonged immobilization, uncorrected vision and hearing deficits, poor sleep hygiene, and isolation from loved ones so common during COVID-19 pandemic. The ABCDEF (A2F) bundle is a means to facilitate implementation of the 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS) Guidelines. In over 25,000 patients across nearly 100 institutions, the A2F bundle has been shown in a dose–response fashion (i.e., greater bundle compliance) to yield improved survival, length of stay, coma and delirium duration, cost, and less ICU bounce-backs and discharge to nursing homes. Springer Berlin Heidelberg 2021-08-16 2021 /pmc/articles/PMC8366492/ /pubmed/34401939 http://dx.doi.org/10.1007/s00134-021-06503-1 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Narrative Review Stollings, Joanna L. Kotfis, Katarzyna Chanques, Gerald Pun, Brenda T. Pandharipande, Pratik P. Ely, E. Wesley Delirium in critical illness: clinical manifestations, outcomes, and management |
title | Delirium in critical illness: clinical manifestations, outcomes, and management |
title_full | Delirium in critical illness: clinical manifestations, outcomes, and management |
title_fullStr | Delirium in critical illness: clinical manifestations, outcomes, and management |
title_full_unstemmed | Delirium in critical illness: clinical manifestations, outcomes, and management |
title_short | Delirium in critical illness: clinical manifestations, outcomes, and management |
title_sort | delirium in critical illness: clinical manifestations, outcomes, and management |
topic | Narrative Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366492/ https://www.ncbi.nlm.nih.gov/pubmed/34401939 http://dx.doi.org/10.1007/s00134-021-06503-1 |
work_keys_str_mv | AT stollingsjoannal deliriumincriticalillnessclinicalmanifestationsoutcomesandmanagement AT kotfiskatarzyna deliriumincriticalillnessclinicalmanifestationsoutcomesandmanagement AT chanquesgerald deliriumincriticalillnessclinicalmanifestationsoutcomesandmanagement AT punbrendat deliriumincriticalillnessclinicalmanifestationsoutcomesandmanagement AT pandharipandepratikp deliriumincriticalillnessclinicalmanifestationsoutcomesandmanagement AT elyewesley deliriumincriticalillnessclinicalmanifestationsoutcomesandmanagement |